Note: Ingredients listed on restricted chemical lists
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
≥90
EC/CAS
9005-64-5
Name of the chemical
polyethyleneglycol sorbitan monolaurate
Concentration
≤3
EC/CAS
128-37-0
Name of the chemical
2,6-di-tert-butyl-p-cresol
Concentration
≤0.1
General Information
Version
Regulatory Affairs
Revision date
2020-08-01
Product name
Doxercalciferol Injection
1.2.1 Relevant identified uses
Pharmaceuticals (For intended use only.) Observe technical data sheet/instructions for use Specific Treatments: Anti-Parathyroid agent
supplier name
Meitheal Pharmaceuticals, Inc
Icons in SDS
Company Information
company name
Meitheal Pharmaceuticals, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
info@meithealpharma.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H227, H373
Hazard statements
Code
Statements
H227
Combustible liquid
Section 2
SECTION 2: Hazards identification
Signal word
Warning Hazard statements H227 - Combustible liquid H373 - May cause damage to organs through prolonged or repeated exposure. (liver) 2.0
Prevention
P280 - Wear protective gloves, protective clothing and eye or face protection. P210 - Keep away from flames and hot surfaces. No smoking. P260 - Do not breathe vapor.
Response
P314 - Get medical advice or attention if you feel unwell.
Storage
P403 + P235 - Store in a well-ventilated place. Keep cool.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Avoid contact with skin and clothing. Wash thoroughly after handling. elements
2.3 Other hazards
Prolonged or repeated contact may dry skin and cause irritation.
2.1 Classification of the substance or mixture
H373 SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) -